News

Reuters6mon
Gilead appoints Sanofi official Dietmar Berger as next chief medical officer
Gilead Sciences said on Thursday it has appointed Sanofi's Dietmar Berger as its chief medical officer, replacing incumbent Merdad Parsey, who is preparing to leave early next year.
FierceBiotech28d
To Gilead’s new CMO, pipeline diversification is key
Dietmar Berger, M.D., Ph.D., joined Gilead Sciences as chief medical officer at the start of this year after the company’s oncology department suffered some prominent setbacks. The run of bad ...
NBC 10 Philadelphia19d
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer - NBC10 Philadelphia
Berger said there are early signs that the combination may also help patients live longer, but the data is still new. Gilead is also studying Trodelvy as a first-line treatment in another type of ...
Oncology Nurse Advisor9d
Sacituzumab Govitecan Meets Endpoint in First-Line mTNBC Trial
The ASCENT-03 trial is a phase 3 study assessing the efficacy and safety of sacituzumab govitecan compared with physician’s choice of treatment in patients with previously untreated, locally advanced, ...
Reuters2mon
Gilead says Trodelvy-Keytruda combo effective for aggressive breast cancer type - Reuters
Dietmar Berger, Gilead's chief medical officer, said that with current treatment, patients can expect five to seven months of progression-free survival - the time until the disease begins to worsen.
NBC Bay Area20d
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer - NBC Bay Area
Berger said there are early signs that the combination may also help patients live longer, but the data is still new. Gilead is also studying Trodelvy as a first-line treatment in another type of ...
NBC Los Angeles20d
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer - NBC Los Angeles
Berger said there are early signs that the combination may also help patients live longer, but the data is still new. Gilead is also studying Trodelvy as a first-line treatment in another type of ...
NBC 6 South Florida19d
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer - NBC 6 South Florida
Berger said there are early signs that the combination may also help patients live longer, but the data is still new. Gilead is also studying Trodelvy as a first-line treatment in another type of ...
NBC Washington19d
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer - NBC4 Washington
Berger said there are early signs that the combination may also help patients live longer, but the data is still new. Gilead is also studying Trodelvy as a first-line treatment in another type of ...
NBC DFW19d
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer - NBC 5 Dallas-Fort Worth
Berger said there are early signs that the combination may also help patients live longer, but the data is still new. Gilead is also studying Trodelvy as a first-line treatment in another type of ...
NBC Chicago19d
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer - NBC Chicago
Berger said there are early signs that the combination may also help patients live longer, but the data is still new. Gilead is also studying Trodelvy as a first-line treatment in another type of ...